Senior Scientist, Translational Research (Immunohistochemistry)

Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s clinical-stage pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies as single agents and as part of combination regimens to treat a range of solid tumors. For more information, visit and follow the Company on  LinkedIn and  X.

We are seeking a experienced and highly motivated Senior Scientist, Translational Research to join our growing Research organization. This role will be instrumental in advancing tissue-based biomarker strategies across our oncology portfolio, with a particular emphasis on immunohistochemistry (IHC), translational biology, and biomarker development.

You will lead the design, execution, and interpretation of tissue-based translational studies supporting discovery and preclinical-stage programs. You will be responsible for developing and implementing biomarker strategies that enhance our understanding of target biology and expression, mechanism of action, and pharmacodynamic activity.

You will work closely with Research, Translational Medicine, Clinical Development, Regulatory Affairs, and external partners to generate data that drives key development decisions and supports precision medicine approaches.